Market evolution: Hearing aids (CN 902140) — 2015–2025

Introduction

This report examines the evolution of European Union trade in hearing aids (excluding parts and accessories) under customs code 902140 over the period 2015–2025. The analysis draws on EU-level trade data covering imports, exports, production volumes, and structural indicators. Over this decade, the EU hearing aid trade landscape underwent significant transformation: the Union consolidated its position as a major net exporter, production shifted markedly toward higher-value outputs, and supply chains—particularly on the import side—reoriented away from traditional partners toward Southeast Asia. The following sections detail these dynamics.

1. The EU's emergence as a dominant net exporter

The most striking feature of the 2015–2025 period is the dramatic shift in the EU's trade position. While the Union began the period as a marginal net importer, it ended it as a substantial net exporter of hearing aids.

1.1 From trade deficit to sustained surplus

In 2015, EU imports (€556.6 million) exceeded exports (€670.6 million) by a modest margin, yielding a trade balance of €114.0 million. By 2025, exports had grown to €975.9 million while imports stood at €730.7 million, expanding the surplus to €245.2 million—a 115% increase. The net import reliance metric tells an even more dramatic story, shifting from a positive 3.6% in 2015 to an extreme negative value of −357.0% by 2025, reflecting the extent to which the EU's export activity now dwarfs its import needs.

1.2 Volumes grew far faster than values—prices fell sharply

The expansion of EU exports was driven primarily by surging volumes rather than rising unit values. Export quantities measured in tonnes rose from 189.1 t to 631.1 t (+233.8%), and the supplementary unit count (number of items) nearly doubled from 3,958,899 to 8,164,940 (+106.2%). However, export prices fell significantly: the price per tonne declined from €3,331,344 to €1,434,187 (−56.9%), and the price per unit fell from €169.40 to €119.53 (−29.4%). A similar pattern characterises imports: tonnage rose 112.6% and item counts grew 128.6%, while per-unit import prices fell 42.6% to €66.76.

This price compression likely reflects a combination of technological maturation, intensified competition (particularly from Asian manufacturers), and the growing adoption of over-the-counter (OTC) hearing devices that expand the market toward lower price points.

1.3 Growing export propensity signals a strategic outward orientation

The EU's export propensity—exports as a share of production—surged from 36.1% to 187.9% (a 420% increase), while trade intensity rose from 54.3% to 141.9%. These figures indicate that EU-based producers are increasingly oriented toward global markets, with export volumes now substantially exceeding domestic production volumes—a pattern consistent with the EU serving as a re-export and distribution hub for hearing aids assembled or manufactured within the bloc.

2. Structural transformation of production and the rise of Poland

Behind the aggregate trade figures lies a profound restructuring of the EU's hearing aid production landscape, characterised by concentration, specialisation, and a geographic eastward shift.

2.1 Production volumes halved, but value was preserved

EU hearing aid production measured in item counts fell from 2,780,477 units in 2015 to 1,500,000 units in 2025 (−46.1%). Despite this, the production value remained broadly stable, moving from €735.9 million to €800.0 million (+8.7%). This implies a near-doubling of the average value per produced unit, suggesting that EU manufacturing has shifted toward higher-end, technology-intensive hearing aid models.

2.2 Poland emerged as the EU's hearing aid export powerhouse

The most remarkable specialisation story is Poland's rise. Polish hearing aid exports exploded from €136.9 million in 2015 to €670.0 million in 2025—an increase of 389.2%. Poland now accounts for 44.2% of the EU's hearing aid export value and holds a revealed comparative advantage (RCA) of 6.66, the highest in the bloc. This is likely driven by the presence of major manufacturers (e.g., Sonova, GN ReSound) establishing or expanding production facilities in Poland, attracted by skilled labour at competitive costs and EU single-market access.

2.3 Denmark's decline and the reshuffling of EU exporters

Denmark, once the EU's largest exporter of hearing aids at €375.8 million in 2015, saw its exports fall to €87.8 million by 2025 (−76.6%). Denmark's RCA in 2025 is a mere 0.50. This decline is striking given that Denmark hosts two of the world's largest hearing aid companies (GN Group and Demant). The data likely reflects a strategic relocation of production and export logistics to continental Europe—particularly Poland—rather than a decline in Danish-headquartered firms' global market share.

Germany (+133.5% to €101.1 million), the Netherlands (+76.4% to €72.6 million), and France (which collapsed from €36.2 million to €2.5 million, −93.0%) illustrate a broader reshuffling. Germany's RCA stands at 1.60, confirming moderate specialisation, while France has essentially exited hearing aid exports.

2.4 Export market diversification reduced concentration

The export-side Herfindahl-Hirschman Index (HHI) by value fell from 2,496 to 1,623 (−35%), indicating that EU export destinations have become meaningfully more diversified. While the United States remains the largest single destination (€358.4 million in 2025, up 12.1% from €319.7 million), the UK (€109.3 million, +126.5%), Norway (€60.9 million, +241.6%), Switzerland (€61.4 million, +176.3%), and Türkiye (€31.2 million, +382.2%) have all gained relative importance. This diversification reduces the EU's vulnerability to demand shocks in any single market.

3. Reorientation of import supply chains toward Southeast Asia

On the import side, the 2015–2025 period witnessed a dramatic shift in sourcing patterns, with Southeast Asian nations displacing the United Kingdom as key suppliers and import concentration rising.

3.1 Vietnam and Malaysia surged; the UK collapsed

The most notable development among EU import partners is the meteoric rise of Vietnam: EU imports from Vietnam grew from €9.6 million in 2015 to €167.2 million in 2025—a staggering 1,643.6% increase. Vietnam now ranks as the EU's second-largest hearing aid supplier. Malaysia followed a similar trajectory, growing from virtually zero (€173) to €39.4 million.

Conversely, the United Kingdom—once the EU's fourth-largest supplier at €109.6 million—saw its exports to the EU collapse to €4.1 million (−96.3%). This near-total withdrawal coincides with Brexit and the establishment of new customs barriers and regulatory divergence between the UK and the EU market.

3.2 China remained dominant but faces rising Southeast Asian competition

China continues to be the EU's largest import source at €264.0 million in 2025 (+49.4% from 2015). However, China's share is being eroded by the rapid growth of Vietnamese and Malaysian suppliers. The Philippines also emerged as a minor but fast-growing source (€5.8 million, up from €30,150 in 2015). This Southeast Asian expansion likely reflects supply chain diversification strategies by multinational hearing aid companies, as well as the broader trend of electronics manufacturing relocating to lower-cost ASEAN economies.

The import-side HHI by value rose from 1,994 to 2,563 (+28.5%), indicating that while new suppliers emerged, the overall market became more concentrated—driven by China's continued dominance and the UK's exit distributing share unevenly.

3.3 Supply shocks highlighted price vulnerability

The volatility analysis reveals that the most significant supply shock in the period was a price shock on Chinese imports in 2022, with an abnormality score of 297.2 and a price shift of +135.2%. This coincides with post-COVID-19 logistics disruptions and China's intermittent lockdowns. Smaller export-side price shocks were detected for Uzbekistan (2020, +384.3%) and Colombia (2018, +110.5%), but these involved negligible trade shares (<1% of EU exports).

Among import partners, the Philippines (coefficient of variation = 1.56) and Japan (CV = 2.22) exhibited the highest volatility, reflecting episodic and unstable trade flows. Vietnam, despite its rapid growth, maintained moderate volatility (CV = 0.62), suggesting a more sustained structural increase rather than erratic swings.

Conclusion

The EU hearing aid market (CN 902140) underwent three defining transformations between 2015 and 2025. First, the Union consolidated its position as a major net exporter, with export volumes more than doubling and the trade surplus expanding from €114 million to €245 million. Second, production shifted decisively toward higher-value outputs, with unit values roughly doubling even as item counts fell—driven in large part by Poland's emergence as the bloc's dominant hearing aid export hub, displacing Denmark. Third, import supply chains reoriented sharply toward Southeast Asia, with Vietnam rising from a marginal supplier to the EU's second-largest import source, while the UK's post-Brexit near-exit from EU hearing aid trade left a gap that Asian manufacturers filled.

Looking ahead, several structural tensions are worth monitoring: the EU's extremely high export propensity (188%) and negative net import reliance (−357%) suggest an outward-facing model that may be exposed to demand-side risks in key markets like the United States; the concentration of supply in a small number of Asian partners introduces geopolitical and logistical vulnerabilities (as the 2022 Chinese price shock demonstrated); and the continued compression of per-unit prices may pressure margins for EU-based producers even as volumes grow. The hearing aid market is poised at the intersection of demographic ageing, digital health innovation, and shifting global trade patterns—making its evolution one to watch closely.